What happens when data/market exclusivity is given to pesticides in India? Who gains? Who Loses?
#pesticide #patent #dataexclusivity #regulatorydataprotection #generic #farmer
@DPIITGoI @CimGOI @PiyushGoyal @ChouhanShivraj @AgriGoI @icarindia @EconomicTimes @dcpcindia @JPNadda
5
6
494
24 Dec 2025
Reasons as to why Data Exclusivity is bad for India's Farm Economy and Agrochemicals Export. For more details see the CCFI paper 👇
global-agriculture.com/wp-co…
#dataexclusivity #RDP #IPR #patent
@AgriGoI @DoC_GoI @DPIITGoI @OEA_DPIIT @EACtoPM @PiyushGoyal @ChouhanShivraj
8
3
548
Star performers in India’s chemical exports and danger from data exclusivity. Powerful policy advocacy slide here👇🏻
#dataexclusivity #tripplus #export #pharamaceuticals #agrochemicals #tradesurplus #chemicals
@CimGOI @DoC_GoI @dgftindia @DPIITGoI @Pharmadept @IPAOfficialPage
1
2
426
TRIPS clauses like #dataexclusivity would be devastating. This will delay the launch of more affordable generic drugs on which Indian but also many other patients from lower income countries rely. 🇨🇭 should stop negotiating TRIPS clauses, and 🇮🇳 stand firm on rejecting them
7 Feb 2024
I hope Indian government would reject acceptance of any harmful intellectual property provisions in its trade talks with EFTA. Millions of lives depend on affordable Indian generics that can get impacted otherwise theprint.in/health/govt-depa…
6
8
1,020
1 Mar 2023
PIJIP Post Doctoral Fellow @mikepalmedo published a paper in the Journal of Globalization and Development. Evaluating the Impact of #DataExclusivity on the Price of #Pharmaceutical Imports.
For more information:
wcl.american.edu/impact/init…
2
118
23 Feb 2023
New in the J. of Globalization & Development 🎉🎉
Evaluating the Impact of #DataExclusivity on the Price of #Pharmaceutical Imports
Large price ⬆️ when US #FTA partners enact data excl. The impact occurs after a lag, b/c the law only applies to new drugs doi.org/10.1515/jgd-2021-001…
7
15
5,643
Do #IntellectualProperty legal requirements - #Patents & #DataExclusivity - affect access to medicines? #BrigitteTenni & co looked at the evidence.
ow.ly/MycX50IRVgt
@sumitkane @UniMelbMDHS @bmcpake
#GenericMedicines #CompulsoryLicencing #TRIPS
2
2 Nov 2021
@ThiruGeneva #DataExclusivity is a #TRIPS-Plus concept non-existent in Art 39(3).It will lead to illegal #Patent term extension,unnecessary repeated clinical tests,delays entry of affordable generic medicines in market,stifles competition,blocks price reduction & cheap medicines.
2 Nov 2021
During the @wto Trade Policy Review of India on 6 January 2021 and 8 January 2021, Switzerland asked India questions related to data-exclusivity and TRIPS article 39(3). India provided a lengthy response.
3
21 Oct 2021
Tues Oct 26: I present "The Impact of #DataExclusivity on #Pharmaceutical Import Prices" at #IPWeek2021.
Its an empirical study of a common #TRIPS #IPR policy.
Thanks to @gcip_2021 for organizing simultaneous translation into Spanish & Portuguese!
tinyurl.com/palmedo-ipweek20…
1
3
27 May 2021
.@MSF_access analysis of #EU position on #CompulsoryLicenses and #TRIPSwaiver notes the EU #DataExclusivity regulation would block registration of generics, "regardless of patent protection". The waiver needs to cover a broad scope of rights. msfaccess.org/analysis-eu-po… #COVID19
7
7
27 Apr 2021
New empirical evidence shows that prices of imported #medicines increased in 42 countries that implement test #dataexclusivity, a #TRIPSAgreement-plus protection required under many #FTAs. See bu.edu/gdp/files/2021/04/GEG…. See also southcentre.int/research-pap…; southcentre.int/policy-brief…
3
6
17 Dec 2020
#EU #FTAs w/ #developingcountries contain #IP chapters that extend #patent terms & #dataexclusivity for #pharmaceuticalproducts. Implementation would damage their #health sectors & economies. They should not be forced to adopt such laws or if so, there should be conditions. 1/2
1
4
5
22 Jun 2020
SC Paper:'#PublicHealth & Plain Packaging of #Tobacco: An #IP Perspective' & PolicyBrief: Evolution of #DataExclusivity for #Pharmaceuticals in FTAs-featured @info_justice infojustice.org/archives/423…; infojustice.org/archives/423…; Full Text southcentre.int/research-pap…; southcentre.int/policy-brief…
3
3
.@TAMULawSchool profs @sraglaw (with @Jkimball237 @AccessibleMeds) and @profpeteryu publish articles in @PacificMcGeorge Law Review symposium on changing #pharma regulation #DataExclusivity #ChinaIP ow.ly/EeSv50zWWSI
2
5
29 Apr 2020
#Dataexclusivity, a #TRIPSAgreement Plus requirement established in FTAs can have a negative impact on #accesstomedicines in developing countries. See NEW @South_Centre Policy Brief by @waelarmouti on how countries can mitigate its effects on #publichealth southcentre.int/policy-brief…
13
8
1 Apr 2020
New @south_centre Research Paper discusses how FTA-acquired obligations to provide test #DataExclusivity for #biologics can delay access to affordable #biosimilars. Read southcentre.int/research-pap… @Zele_Tem
6
8
5 Feb 2020
In a theoretical model & corresponding lab experiment, BCCP Doctoral Students F.Heiny, T. Li & M.Tolksdorf show that #DataExclusivity results in trade-off for consumers between individual and collective benefit of #privacy | bit.ly/382nBYy | #GDPR
29 Jan 2020
Dr. Carlos Correa, @South_Centre Executive Director, stressed the role of #TRIPSflexibilities to enhance #accesstomedicines & need to avoid TRIPS-plus rules in #FTAs, such as #patent term extensions & #dataexclusivity, at Prince Mahidol Award Conference Side Meeting, Bangkok #UHC
13
24
17 Dec 2019
Suppression of #DataExclusivity for biological medicines & other reforms in #IntellectualProperty chapter of #USMCA are a step forward to facilitate #AccessTomedicines, consistently with #TRIPSflexibilities See waysandmeans.house.gov/sites…
7
10
23 Oct 2019
#DataExclusivity constitutes an obstacle to #access2meds by delaying market entrance of generic versions.@Trade_EU keeps on demanding it from partners when negotiating trade deals (e.g. Ukraine EU DCFTA and Truvada)
1
3